DD251131A5 - Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene - Google Patents

Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene Download PDF

Info

Publication number
DD251131A5
DD251131A5 DD86285893A DD28589386A DD251131A5 DD 251131 A5 DD251131 A5 DD 251131A5 DD 86285893 A DD86285893 A DD 86285893A DD 28589386 A DD28589386 A DD 28589386A DD 251131 A5 DD251131 A5 DD 251131A5
Authority
DD
German Democratic Republic
Prior art keywords
ethyl
indol
salt
hydroxy
item
Prior art date
Application number
DD86285893A
Other languages
German (de)
English (en)
Inventor
Wolfgang Froestl
Angelo Storni
Beat Schmitz
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD251131A5 publication Critical patent/DD251131A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • GPHYSICS
    • G05CONTROLLING; REGULATING
    • G05BCONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00Program-control systems
    • G05B2219/30Nc systems
    • G05B2219/35Nc in input of data, input till input file format
    • G05B2219/35287Verify, check program by drawing, display part, testpiece

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DD86285893A 1985-01-03 1986-01-02 Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene DD251131A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1385 1985-01-03

Publications (1)

Publication Number Publication Date
DD251131A5 true DD251131A5 (de) 1987-11-04

Family

ID=4177425

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86285893A DD251131A5 (de) 1985-01-03 1986-01-02 Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene

Country Status (12)

Country Link
EP (1) EP0187619A3 (fr)
JP (2) JPS61161258A (fr)
KR (1) KR870006036A (fr)
AU (1) AU5178786A (fr)
DD (1) DD251131A5 (fr)
DK (1) DK886A (fr)
FI (1) FI855182A7 (fr)
GR (1) GR860003B (fr)
HU (1) HUT39442A (fr)
NO (1) NO860008L (fr)
PT (1) PT81781B (fr)
ZA (2) ZA869B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907974A1 (de) * 1989-03-11 1990-09-13 Merck Patent Gmbh Indolderivate
US5428043A (en) * 1990-02-08 1995-06-27 Pfizer Inc. Tricyclic-cyclic amines as novel cholinesterase inhibitors
TW197442B (fr) * 1990-02-08 1993-01-01 Pfizer
KR100457857B1 (ko) * 2002-05-23 2004-11-18 (주) 비엔씨바이오팜 2-[2-(3-인돌릴)에틸아미노]피리딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
MX2007007434A (es) * 2004-12-20 2007-07-17 Hoffmann La Roche Derivados de 4-aminopiperidina.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075986A (en) * 1958-01-09 1963-01-29 Rhone Poulenc Sa (1-piperdidylalkyl) derivatives of 3-indole
US3183235A (en) * 1961-06-27 1965-05-11 Sterling Drug Inc 1-[3-, 2-, and 1-indolyl-lower-alkanoyl] piperidines
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3821387A (en) * 1965-10-23 1974-06-28 Robins Co Inc A H The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
DE3233553A1 (de) * 1982-09-10 1984-03-15 Merck Patent Gmbh, 6100 Darmstadt Pyrrolderivate
DE3342632A1 (de) * 1983-11-25 1985-06-05 Merck Patent Gmbh, 6100 Darmstadt Indolderivate

Also Published As

Publication number Publication date
DK886A (da) 1986-07-04
JPS61161258A (ja) 1986-07-21
ZA8610B (en) 1986-08-27
PT81781B (de) 1987-11-05
DK886D0 (da) 1986-01-02
EP0187619A2 (fr) 1986-07-16
GR860003B (en) 1986-04-25
HUT39442A (en) 1986-09-29
FI855182L (fi) 1986-07-04
JPS61161279A (ja) 1986-07-21
AU5178786A (en) 1986-07-17
EP0187619A3 (fr) 1987-08-26
FI855182A7 (fi) 1986-07-04
FI855182A0 (fi) 1985-12-30
ZA869B (en) 1986-08-27
PT81781A (de) 1986-02-01
NO860008L (no) 1986-07-04
KR870006036A (ko) 1987-07-08

Similar Documents

Publication Publication Date Title
DE69413542T2 (de) Perhydroisoindolderivate als substanz p antagonisten
DE69008012T2 (de) 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen.
EP0532456B1 (fr) Dérivés de l'acyle-1-pipéridine et leur utilisation comme antagonistes du substance P
DE2935772A1 (de) Dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE69714265T2 (de) Tetrahydrochinolinderivate als eaa antagonisten
HU193229B (en) Process for producing 1-benzyl-amino-methyl-pyrrolidinones and their acid addition salts
DE69006907T2 (de) Arylthiazolylimidazole als 5HT3-Antagonisten.
DE69622731T2 (de) Tetrahydrochinoline als nmda antagonisten
DE69324212T2 (de) Indol-7-carboxamide Derivate als Analgetika
DD279674A5 (de) Verfahren zur herstellung von hydrierten 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen
DE2822465C2 (de) 2-substituierte trans-5-Phenyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indolderivate und diese enthaltende Arzneimittel
DE69634183T2 (de) Substituierte Heterocyclen
DD251131A5 (de) Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene
DE68925173T2 (de) 4-Methyl und 4-Ethyl substituierte Pyrrolidin-2-one
EP0519291A1 (fr) 2,3-Dihydropyrano (2,3-b) pyridines amino-méthyl-substituées, procédé pour leur préparation et leur utilisation en tant que médicaments
DE60106572T2 (de) IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN
EP0389425B1 (fr) Benzothiopyranylamines
DE69526595T2 (de) Pyridoncarbonsäurederivate substituiert von bicyclischer aminogruppe, deren ester und salze, und bicyclisches amin als zwischenprodukt davon
DE60010855T2 (de) Phenylsulphonylderivative als 5-ht rezeptorliganden
EP0187122A2 (fr) Azacycloalkanes, azacycloalcènes 1,3,4-trisubstitués
EP0128120A2 (fr) Oxazolidinones substituées
DD257430A5 (de) Verfahren zur herstellung von pyrrolo(1,2-a)(4,1)benzoxarepinen
DD216456A5 (de) Verfahren zur herstellung neuer aralkyltriazolverbindungen
DE68913167T2 (de) Indol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE69821642T2 (de) Substituierte oxime als neurokinin antagonisten